Former NCI official’s nonprofit seeks to tell the stories of cancer patients Patient Action for Cancer Research aims to show impact of federal research

Experts warn that loss of carcinogen surveillance threatens to increase cancer incidence

Testing of chemicals for potential cancer causation (carcinogenesis) has long been a successful disease-prevention initiative of the highest priority.

October 24, 2025

Vol.51 No.39

By David M. DeMarini, Rosalie Elespuru, Miriam C. Poirier and Errol Zeiger

News Analysis Regulatory News

How animal testing became a MAHA political wedge issue
While cancer scientists say NIH, FDA moves are premature, animal rights advocates say changes aren’t drastic enough

Bowing to the growing animal rights movement, FDA and NIH have made policy changes to discourage animal testing, instead favoring alternative research models.

October 17, 2025

Vol.51 No.38

By Claire Marie Porter and Jacquelyn Cobb

Podcast

Pulitzer-winning healthcare reporter Laurie McGinley on her shift to advocacy work with PACR

“Patient stories, as you know, can either make or break a story,” said Laurie McGinley, a former health and science editor at The Washington Post who is now on the board of Patient Action for Cancer Research, or PACR, a new advocacy organization aimed at organizing and amplifying patient voices in an effort to protect life-saving federal health research.

October 08, 2025

Vol.51 No.36

Guest Editorial

Seeding NCORPs with academically-focused oncologists can advance the national research agenda

Fiscal and strategic uncertainty abound at our leading academic medical centers. Job cuts to hospital staff (University of Southern California), research nurses (Vanderbilt) and librarians (Duke) are changing the landscape of our leading centers.

October 03, 2025

Vol.51 No.36

By Amarinthia (Amy) Curtis

Guest Editorial

Population-based cancer surveillance is a national treasure at risk

There is a silent crisis in cancer research that underpins nearly all aspects of the work we do to combat this disease.

September 26, 2025

Vol.51 No.35

By Eric B. Durbin, Karen L. Knight, Betsy Kohler and Sarah Nash

Clinical Trials & Tribulations

Earlier diagnosis, better outcomes: Telemedicine has found a home in oncology

We are rapidly approaching the Sept. 30 planned expiration of telemedicine coverage under Medicaid. Letting this authorization expire is short-sighted. As an oncologist, I believe there are multiple compelling, non-pandemic reasons for telemedicine to remain a permanent fixture in cancer care.

September 26, 2025

Vol.51 No.35

By Hardeep Phull

Former NCI official’s nonprofit seeks to tell the stories of cancer patients

Patient Action for Cancer Research aims to show impact of federal research

YOU MAY BE INTERESTED IN

Experts warn that loss of carcinogen surveillance threatens to increase cancer incidence

How animal testing became a MAHA political wedge issue
While cancer scientists say NIH, FDA moves are premature, animal rights advocates say changes aren’t drastic enough

Pulitzer-winning healthcare reporter Laurie McGinley on her shift to advocacy work with PACR

Seeding NCORPs with academically-focused oncologists can advance the national research agenda

Population-based cancer surveillance is a national treasure at risk

Earlier diagnosis, better outcomes: Telemedicine has found a home in oncology

Renew today!

Subscriber content

Never miss an issue!

Login

Former NCI official’s nonprofit seeks to tell the stories of cancer patients

Patient Action for Cancer Research aims to show impact of federal research

YOU MAY BE INTERESTED IN

Experts warn that loss of carcinogen surveillance threatens to increase cancer incidence

How animal testing became a MAHA political wedge issueWhile cancer scientists say NIH, FDA moves are premature, animal rights advocates say changes aren’t drastic enough

Pulitzer-winning healthcare reporter Laurie McGinley on her shift to advocacy work with PACR

Seeding NCORPs with academically-focused oncologists can advance the national research agenda

Population-based cancer surveillance is a national treasure at risk

Earlier diagnosis, better outcomes: Telemedicine has found a home in oncology

Never miss an issue!

Login

How animal testing became a MAHA political wedge issue
While cancer scientists say NIH, FDA moves are premature, animal rights advocates say changes aren’t drastic enough